We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Collaboration to Produce New High-Throughput Mass Spectrometry System

By LabMedica International staff writers
Posted on 20 Jun 2011
Two major developers of mass spectrometry instruments are collaborating to produce a new analytical system to cater to the requirements of researchers and analysts demanding dedicated hardware for high-throughput pharmaceutical applications, forensic toxicology, and food safety testing.

The two companies, AB SCIEX (Foster City, CA, USA) and Phytronix Technologies (Quebec City, Canada) are working to integrate Phytronix's LDTD (Laser Diode Thermal Desorption) Ion source with the AB SCIEX TripleTOF 5600 Mass Spectrometry System.

The AB SCIEX TripleTOF 5600 System already offers a fast and sensitive high-resolution mass spectrometer for high-performance qualitative and quantitative analysis. More...
This technology will be complemented by Phytronix's LDTD Ion Source, which is reputed to be the fastest high throughput solution on the market. This innovative design is based on a shotgun approach where the sample is introduced in the mass spectrometer by a rapid laser thermal desorption process and is ionized by an atmospheric pressure chemical reactions (LDTD-APCI).

"The combination of LDTD and the AB SCIEX Triple TOF 5600 System provides an unmatchable tool for drug discovery as well as clinical research, forensics, and food safety analysis. Our LDTD Ion Source introduces a sample by a rapid laser thermal desorption process into an AB SCIEX MS/MS, ionizing it via atmospheric pressure chemical ionization without mobile phase. This "shotgun" approach, coupled with the TripleTOF system, offers a full MS analysis with the exact mass in less than four seconds," said Jean Lacoursière, president of Phytronix Technologies.

Dave Hicks, a vice president at AB SCIEX, said, "AB SCIEX is committed to the high-throughput market, and with the AB SCIEX TripleTOF 5600 System setting a new standard in innovation, we are confident that we can push the limits in this area better than anyone else. Several of our customers are already working with LDTD-MS/MS, so this integration with Phytronix is a natural step forward in our strategy to broaden the options for scientists and lab analysts utilizing high-throughput workflows."

Related Links:
AB SCIEX
Phytronix Technologies


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
Electrolyte Analyzer
BKE-B
HPV Test
Allplex HPV28 Detection
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Researchers developed three mathematical biomarkers from routine PSA blood tests that may help predict early prostate cancer treatment outcomes and personalize adaptive therapy (Image Credit: Adobe Stock)

Mathematical Biomarkers Use Routine Blood Tests to Guide Adaptive Prostate Cancer Therapy

Personalizing systemic therapy for prostate cancer remains challenging because tumors can evolve under treatment pressure, driving resistance and early relapse. Continuous high-dose regimens may initially... Read more

Molecular Diagnostics

view channel
Image: The duet mosaic family comprises duet +modC mosaic and duet 6-base mosaic, two cfDNA-optimized multiomic sequencing workflows for liquid biopsy and translational research. (Photo courtesy of bimodal)

New Liquid Biopsy Workflow Maximizes Tumor Signals from Limited Blood Samples

Liquid biopsy seeks to detect tumor-derived signals from small blood samples, but circulating cell-free DNA is scarce and heterogeneous, limiting sensitivity. Combining complementary signals such as methylation,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.